Cargando…
Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
The early results (e.g., patient survival) of RFA for the treatment of patients with NSCLC and pulmonary metastasis from various primary lesions including colorectal cancer, lung cancer, hepatocellular carcinoma, renal cell carcinoma, and sarcoma appear encouraging and suggest the potential to offer...
Autores principales: | Hiraki, Takao, Kanazawa, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483774/ https://www.ncbi.nlm.nih.gov/pubmed/23125926 http://dx.doi.org/10.1155/2012/196173 |
Ejemplares similares
-
Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014) -
EUS-guided radiofrequency ablation for a left adrenal oligometastasis of an esophageal adenocarcinoma
por: Inderson, Akin, et al.
Publicado: (2018) -
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
por: Mazzola, Rosario, et al.
Publicado: (2020) -
Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease
por: Macagno, Alban, et al.
Publicado: (2022) -
Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)